Clinical Trial Update: Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing denosumab with zoledronic acid for treating bone metastases in advanced cancer or multiple myeloma has completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Cancer
• Multiple Myeloma

Drugs mentioned

• Denosumab (denosumab)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Amgen | Conditions: Bone Metastases | Phase 3 | Status: COMPLETED | Results posted: 2014-04-09